Re-inventing a better wheel? Serplulimab for squamous cell lung cancer
Cancer Cell · 2024
DOI: 10.1016/j.ccell.2024.01.004 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2024. Verfasst von Derek De-Rui Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine,…
Zitieren
APA
Huang, D. D., & Yang, J. C. (2024). Re-inventing a better wheel? Serplulimab for squamous cell lung cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.01.004
Vancouver
Huang DD, Yang JC. Re-inventing a better wheel? Serplulimab for squamous cell lung cancer. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.01.004
BibTeX
@article{Huang2024,
author = {Huang, Derek De-Rui and Yang, James Chih-Hsin},
title = {Re-inventing a better wheel? Serplulimab for squamous cell lung cancer},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.01.004}
}
EUVIMED